671 related articles for article (PubMed ID: 33724323)
1. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
[TBL] [Abstract][Full Text] [Related]
2. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
[TBL] [Abstract][Full Text] [Related]
3. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
Bassuk SS; Manson JE; Lee IM; Cook NR; Christen WG; Bubes VY; Gordon DS; Copeland T; Friedenberg G; D'Agostino DM; Ridge CY; MacFadyen JG; Kalan K; Buring JE
Contemp Clin Trials; 2016 Mar; 47():235-43. PubMed ID: 26767629
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
[TBL] [Abstract][Full Text] [Related]
7. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
Okereke OI; Reynolds CF; Mischoulon D; Chang G; Vyas CM; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Manson JE
JAMA; 2020 Aug; 324(5):471-480. PubMed ID: 32749491
[TBL] [Abstract][Full Text] [Related]
8. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE
JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial.
Limonte CP; Zelnick LR; Ruzinski J; Hoofnagle AN; Thadhani R; Melamed ML; Lee IM; Buring JE; Sesso HD; Manson JE; de Boer IH
Diabetologia; 2021 Feb; 64(2):437-447. PubMed ID: 33098434
[TBL] [Abstract][Full Text] [Related]
10. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.
Bischoff-Ferrari HA; Vellas B; Rizzoli R; Kressig RW; da Silva JAP; Blauth M; Felson DT; McCloskey EV; Watzl B; Hofbauer LC; Felsenberg D; Willett WC; Dawson-Hughes B; Manson JE; Siebert U; Theiler R; Staehelin HB; de Godoi Rezende Costa Molino C; Chocano-Bedoya PO; Abderhalden LA; Egli A; Kanis JA; Orav EJ;
JAMA; 2020 Nov; 324(18):1855-1868. PubMed ID: 33170239
[TBL] [Abstract][Full Text] [Related]
11. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.
Orkaby AR; Dushkes R; Ward R; Djousse L; Buring JE; Lee IM; Cook NR; LeBoff MS; Okereke OI; Copeland T; Manson JE
JAMA Netw Open; 2022 Sep; 5(9):e2231206. PubMed ID: 36098968
[TBL] [Abstract][Full Text] [Related]
12. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial.
Chandler PD; Chen WY; Ajala ON; Hazra A; Cook N; Bubes V; Lee IM; Giovannucci EL; Willett W; Buring JE; Manson JE;
JAMA Netw Open; 2020 Nov; 3(11):e2025850. PubMed ID: 33206192
[TBL] [Abstract][Full Text] [Related]
14. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
Forno E; Bacharier LB; Phipatanakul W; Guilbert TW; Cabana MD; Ross K; Covar R; Gern JE; Rosser FJ; Blatter J; Durrani S; Han YY; Wisniewski SR; Celedón JC
JAMA; 2020 Aug; 324(8):752-760. PubMed ID: 32840597
[TBL] [Abstract][Full Text] [Related]
15. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
Hahn J; Cook NR; Alexander EK; Friedman S; Walter J; Bubes V; Kotler G; Lee IM; Manson JE; Costenbader KH
BMJ; 2022 Jan; 376():e066452. PubMed ID: 35082139
[TBL] [Abstract][Full Text] [Related]
17. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.
Scragg R; Stewart AW; Waayer D; Lawes CMM; Toop L; Sluyter J; Murphy J; Khaw KT; Camargo CA
JAMA Cardiol; 2017 Jun; 2(6):608-616. PubMed ID: 28384800
[TBL] [Abstract][Full Text] [Related]
18. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D supplementation on urinary incontinence in older women: ancillary findings from a randomized trial.
Markland AD; Vaughan C; Huang A; Kim E; Bubes VY; Tangpricha V; Buring J; Lee IM; Cook N; Manson JE; Grodstein F
Am J Obstet Gynecol; 2022 Apr; 226(4):535.e1-535.e12. PubMed ID: 34678177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
